PP01.20: Integrating Clinicopathologic and Genomic Features to Identify Patients at Risk of Earlier Progression to First-Line Osimertinib in EGFR-Mutant NSCLC
Year: 2026
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: Federica Pecci, Mark Jeng, Alessandro Di Federico, Marianna Peroni, Federico Monaca, Emanuele Claudio Mingo, Lodovica Zullo, Daniele Marinelli, Andrea Torchia, Francesca Colamartini, Silvia Teresa Riva, Minh Tri Le, Ayesha Aijaz, Maisam Makarem, Eleonora Gariazzo, Biagio Ricciuti, Valentina Santo, Mihaela Aldea, Edoardo Garbo, Francesco Paoloni, Igor Gomez-Randulfe, Andrea De Giglio, Irene Zannini, Sara Stumpo, Francesco Mantuano, Alessandro Leonetti, Michela Verzè, Roberta Minari, Francesco Facchinetti, Stefano Scalera, Marcello Maugeri-Saccà, Amanda Pupo, Stacey Frumm, Xinan Wang, Sara Baglivo, Emanuele Mazzola, Mizuki Nishino, Igor Odintsov, Lynette M. Sholl, Julia Rotow, Jaclyn LoPiccolo, Abdul Rafeh Naqash, Antoine Desilets, Benjamin Besse, David Planchard, Alessio Cortellini, Roberto Ferrara, Giulio Metro, Federico Cappuzzo, Raffaele Califano, Andrea Ardizzoni, Marcello Tiseo, Helena Yu, Pasi A. Jänne
Institutions: Harvard University, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, University of Bologna, University of Manchester, The Christie NHS Foundation Trust, Università Campus Bio-Medico, Campus Bio Medico University Hospital, Institut Gustave Roussy, Instituto Nazionale Tumori Regina Elena, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Centre Hospitalier de l’Université de Montréal, OU Health Stephenson Cancer Center, University of Oklahoma, Brigham and Women's Hospital, Dana-Farber Brigham Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7167248580
Cites:
Cited by:
Related to: